Filtered By:
Management: Mergers and Aquisitions
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 119 results found since Jan 2013.
Ahead of Shire buyout, Takeda sells joint venture and reportedly plans $20B bond deal
Japanese pharmaceutical giant Takeda is boosting its finances ahead of its costly acquisition of Shire plc, selling its stake in a Chinese joint venture for $280 million and reportedly planning a record $20 billion bond deal.
Takeda announced Monday that it had sold its majority stake in a joint venture called Guangdong Techpool Bio-Pharma Co., which sells drugs for pancreatitis and stroke. The move is part of a broader effort by Takeda to ditch assets outside of its core focus areas, including…
Source: bizjournals.com Health Care:Biotechnology headlines - May 22, 2018 Category: Biotechnology Authors: Max Stendahl Source Type: news
A Tale of Two Telehealth Acquisitions
Telemedicine companies are actively looking for ways to open the sector up to broader adoption. Partnerships and acquisitions seem to be the fastest means to that end, as two recent telemedicine deals would suggest.
InTouch Health, a Santa Barbara, CA-based telemedicine firm, said it will acquire REACH Health, an Alpharetta, GA-based telemedicine software company. Shortly after the deal was announced, Boston, MA-based American Well, reported its agreement to acquire Avizia, a prominent player in the acute care telehealth space. Financial terms were not disclosed for either deal.
"The telehealth industry is fragmented and...
Source: MDDI - May 2, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Digital Health Business Source Type: news
Jan Medical begins coop BrainPulse testing with the US Army
Jan Medical said today that it has launched a cooperative research and development deal with the US Army Medical Materiel Agency to evaluate its BrainPulse device.
Jan Medical’s BrainPulse device is designed to non-invasively capture novel physiological signals through a patient’s cardiac output, used to measure vascular and brain tissue conditions, the company said. The data can be used as an ‘aid to diagnoses’ for multiple indications, including concussion and stroke.
Initial testing as part of the R&D program was completed on March 9, with the first user feedback session conducted today, the Mountain View, ...
Source: Mass Device - April 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Neurological Research & Development Jan Medical Source Type: news
HIMSS reports attendance growth for 2018 show
LAS VEGAS - Attendance is up 4% as of the third day of this year's Healthcare...Read more on AuntMinnie.comRelated Reading:
Facebook Live from HIMSS 2018: Day 2
Facebook Live from HIMSS 2018: Day 1
HIMSS: Health info exchange enables better stroke care
HIMSS acquisition expands educational offerings
HIMSS/SIIM paper offers advice on enterprise image viewers
Source: AuntMinnie.com Headlines - March 8, 2018 Category: Radiology Source Type: news
Stryker closes $664m Entellus Medical buy
Entellus Medical (NSDQ:ENTL) said today it closed its $664 million sale to Stryker (NYSE:SYK), becoming a wholly owned subsidiary of the Kalamazoo, Mich.-based medtech firm.
Plymouth, Minn.-based Entellus, founded in 2006, makes a family of minimally invasive balloon device products, including its flagship Xpress device, that are designed to treat blocked sinuses. Earlier this year it closed the $81 million buyout of Spirox and its Latera absorbable nasal implant.
In the deal, Stryker paid $24 per share for each share of Entellus, paying an approximate $664 million for the company.
As part of the completed merger, Ente...
Source: Mass Device - February 28, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Otolaryngology Ear, Nose & Throat Entellus Medical Inc. Stryker Source Type: news
J & J ’ s Cerenovus launches Galaxy G3 mini embolic coil, touts Arise II Embotrap study data
Johnson & Johnson‘s (NYSE:JNJ) Cerenovus division this week announced the launch of its Galaxy G3 Mini embolic coil and released data from a study of its Embotrap device designed to remove clots from the brain following ischemic stroke.
The Galaxy G3 Mini coils are designed to be approximately 25% softer than the Galaxy G3 xsft coils, with an ultra-low coil profile and a primary wind diameter of 0.009 inches, which Cerenovus said is the lowest profile available in its Spectra line.
The newly launched coil is designed to have a random complex shape to make it comformable and enable the device to seek and fill open...
Source: Mass Device - January 26, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Business/Financial News Catheters Clinical Trials Neurological Vascular cerenovus johnsonandjohnson Source Type: news
Jefferson, Magee complete merger
Jefferson Health added its fourth new member since 2015 with the completion of its merger with Magee Rehabilitation Hospital.
The leaders of Jefferson and Magee said Tuesday the integration will enable two organizations, both nationally ranked, to provide “an even higher level of care” to patients regaining independence from spinal cord injury, stroke, brain injury, amputation, multiple sclerosis and/or orthopedic injuries.
Jefferson and Magee have had a clinical affiliation for several decades.…
Source: bizjournals.com Health Care:Biotechnology headlines - January 23, 2018 Category: Biotechnology Authors: John George Source Type: news
Endonovo Therapeutics finally buys Rio Grande Neuroscience assets for nearly $5m
Nearly a year-and-a-half after their planned $22 million merger fell through,Endonovo Therapeutics (OTC:ENDV) said last week that it acquired intellectual property and assets from Rio Grande Neurosciences for $4.5 million.
Rio Grande in August 2016 backed out of deal with Endonovo after seeking to renegotiate its terms when Steven Gluckstern, chairman & CEO of Santa Fe-based Rio Grande, dissolved a binding letter of intent. Los Angeles-based Endonovo, which had raised $10 million to fund the $21.5 million buyout, was to have put up $1.5 million in cash, another $15 million in ENDV shares and $5 million worth ...
Source: Mass Device - December 27, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Wall Street Beat Source Type: news
Integra LifeSciences completes purchase of J & J ’ s Codman Neurosurgery
Integra LifeSciences (Nasdaq: IART) has completed its previously announced $1.045 billion purchase of Johnson & Johnson’s Codman Neurosurgery business, the companies announced today.
“The addition of Codman Neurosurgery expands our global leadership position by creating one of the broadest medical device portfolios in the neurosurgery market,” Peter Arduini, Integra’s president and CEO, said in a news release.
“Our planned investments in product innovation and global infrastructure will allow us to provide more healthcare solutions to surgeons and their patients worldwide,” Arduini said.
Integra...
Source: Mass Device - October 2, 2017 Category: Medical Devices Authors: Chris Newmarker Tags: Business/Financial News News Well Wall Street Beat Codman Neuro Integra LifeSciences Corp. johnsonandjohnson Natus Medical Inc. Source Type: news
Effects of the dimeric PSD-95 inhibitor UCCB01-144 on functional recovery after fimbria-fornix transection in rats
Publication date: Available online 21 September 2017 Source:Pharmacology Biochemistry and Behavior Author(s): Jens Bak Sommer, Anders Bach, Hana Malá, Kristian Strømgaard, Jesper Mogensen, Darryl S. Pickering Pharmacological inhibition of PSD-95 is a promising therapeutic strategy in the treatment of stroke, and positive effects of monomeric and dimeric PSD-95 inhibitors have been reported in numerous studies. However, whether therapeutic effects will generalize to other types of acute brain injury such as traumatic brain injury (TBI), which has pathophysiological mechanisms in common with stroke, is currently uncertain...
Source: Pharmacology Biochemistry and Behavior - September 22, 2017 Category: Biochemistry Source Type: research
Johnson & Johnson hosts launch party for Cerenovus neurovascular biz
Johnson & Johnson (NYSE:JNJ) said today it launched its Cerenovus brand, which combined its Pulsar Vascular and Neuravi acquisitions and its remaining Codman Neuro neurological portfolio.
Cerenovus was launched at the European Society of Minimally Invasive Neurological Therapy’s 9th annual meeting, J&J said.
Johnson & Johnson said that the Cerenovus product portfolio aims to help improve stroke care, with the number of strokes annually projected to rise from 1.1 million in 2000 to 1.5 million by 2025.
“We believe stroke should not be a life sentence. Cerenovus is inspired by our long heritage ...
Source: Mass Device - September 7, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Neurological cerenovus johnsonandjohnson Neuravi Limited Pulsar Vascular Source Type: news
MassDevice.com +5 | The top 5 medtech stories for August 18, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Study: New infrared imaging technique could help detect heart attack, stroke risk
A new near-infrared diagnostic technique could help improve early detection for patients at risk of heart attacks or strokes, according to a new ...
Source: Mass Device - August 18, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news
MassDevice.com +5 | The top 5 medtech stories for July 25, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. How a single drop of blood can detect sepsis
Sepsis can be identified by a single drop of blood, thanks to a lab-on-a-chip device from the University of Illinois.
Researchers at the University of Illinois and the Carle Foundati...
Source: Mass Device - July 25, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Penumbra picks up Italian distributor Crossmed for $9m
Penumbra (NYSE:PEN) said today it paid $9.4 million (EU €8.2 million) for all outstanding shares of Italian Crossmed S.p.a., which operated as the company’s exclusive distributor in Italy, San Marino and the Vatican.
Alameda, Calif.-based Penumbra said that with the acquisition, Crossmed is now a wholly-owned subsidiary of the company. Penumbra added that there are no material relationships between it and any of the sellers other than those pertaining to the acquisition.
In addition to the initial payment, Penumbra said that it will also pay additional milestone payments based on Crossmed’s net revenue, &#...
Source: Mass Device - July 11, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Mergers & Acquisitions Penumbra Inc. Source Type: news
Philips picks up EEG dev Electrical Geodesics for $37m
Royal Philips (NYSE:PHG) said today it has agreed to acquire Electrical Geodesics for $36.7 million (GBP£ 29 million).
Amsterdam-based Philips said that EGI’s portfolio of EEG hardware, software and acquisition sensors would work to complement its existing imaging tech and advanced informatics portfolio for neurological applications.
In the sale, Philips is offering $133.50 (GBP £105.40) for each EGI share, constituting a 36% premium to its June 21 closing value, the company said. The transaction is subject to customary closing conditions and stockholder approval, with a slated completion date in the 3rd quarter ...
Source: Mass Device - June 22, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Mergers & Acquisitions royal-philips Source Type: news
